FARICIMAB and EYE DISORDER

Overview

EYE DISORDER is the #20 most commonly reported adverse reaction for FARICIMAB, manufactured by Genentech, Inc.. There are 110 FDA adverse event reports linking FARICIMAB to EYE DISORDER. This represents approximately 1.0% of all 11,141 adverse event reports for this drug.

Patients taking FARICIMAB who experience eye disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

EYE DISORDER is a less commonly reported adverse event for FARICIMAB, but still significant enough to appear in the safety profile.

Other Side Effects of FARICIMAB

In addition to eye disorder, the following adverse reactions have been reported for FARICIMAB:

• OFF LABEL USE — 2,275 reports
• NO ADVERSE EVENT — 1,900 reports
• VISUAL IMPAIRMENT — 479 reports
• DRUG INEFFECTIVE — 325 reports
• DEATH — 309 reports
• UVEITIS — 309 reports
• EYE INFLAMMATION — 306 reports
• RETINAL THICKENING — 299 reports
• ENDOPHTHALMITIS — 237 reports
• BLINDNESS — 224 reports

Other Drugs Associated with EYE DISORDER

The following drugs have also been linked to eye disorder in FDA adverse event reports:

Does FARICIMAB cause EYE DISORDER?

EYE DISORDER has been reported as an adverse event in 110 FDA reports for FARICIMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is EYE DISORDER with FARICIMAB?

EYE DISORDER accounts for approximately 1.0% of all adverse event reports for FARICIMAB, making it a notable side effect.

What should I do if I experience EYE DISORDER while taking FARICIMAB?

If you experience eye disorder while taking FARICIMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages